Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Edmonton, Calgary, Vancouver WA, Portland OR,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Edmonton, Calgary, Kelowna, Prince George, Vancouver,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase 2, Recruiting

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Edmonton, Saskatoon, Kelowna, Regina, Vancouver, London,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03297606

Phase 2, Recruiting

Immune-Mediated Pathophysiology And Clinical Triage Program

for
Arthritis, Arthralgia
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT04354649

Phase 2, Recruiting

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

for
Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT04358913

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Duration of Anti-PD-1 Therapy in Metastatic Melanoma

for
Unresectable/Metastatic Melanoma
Location: Edmonton, Saskatoon, Regina, Surrey, Vancouver,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT02821013

Phase 3, Recruiting

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

for
Cancer
Location: Edmonton, Saskatoon, Kelowna, Vancouver, Kitchener,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03847649

Phase 2, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Edmonton, Calgary, Seattle WA, Federal Way WA,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase 3, Recruiting

BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours

for
Colorectal Cancer, Pancreatic Cancer, Gastric Cancers,
Location: Edmonton, Hamilton, Toronto, Ottawa, Montreal
Sponsor: Bold Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04421820

Phase 1, Phase 2, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Edmonton, Calgary, Vancouver, Seattle WA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase 1, Phase 2, Recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

for
Stem Cell Transplant Complications
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05421416

Phase 2, Recruiting

Prehab Prior to Stem Cell Transplantation in Multiple Myeloma

for
Multiple Myeloma, Exercise, Prehabilitation
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06280924

Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Edmonton, Calgary, Coeur d'Alene ID, Edmonds WA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Edmonton, Calgary, Vancouver, Tacoma WA, Portland OR,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

for
Multiple Myeloma
Location: Edmonton, Salt Lake City UT, Reno NV, St. George UT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05623020

Phase 3, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Edmonton, Vancouver, Seattle WA, Aurora CO,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Edmonton, Rochester MN, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase 3, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Edmonton, Vancouver, Seattle WA, Portland OR,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

for
Lung Neoplasm, Cell Hypoxia
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT00765986

Recruiting

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

for
Colorectal Cancer, Liver Metastasis Colon Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05775146

Phase 2, Recruiting